TCRX TScan Therapeutics, Inc.
TScan Therapeutics, Inc. (TCRX) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: December 23, 2025 .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Buy | 6,232 | $0.90 | $5.6K | 8,019,148 | |||
| Buy | 75,500 | $0.90 | $68.0K | 8,012,916 | |||
| Buy | 80,069 | $0.90 | $72.0K | 7,937,416 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.